Charles River Laboratories Acquires HemaCare Corporation

January 8, 2020

Charles River Laboratories Acquires HemaCare Corporation

Contract research organization, Charles River Laboratories has acquired HemaCare Corporation. The acquisition was completed at $380 million; HemaCare is a leading producer of human-derived cellular products for the cell therapy market. Yourway’s global, integrated depot network supports the transport of highly sensitive drugs and clinical trial material across borders.

Back to Index

Media

Upcoming Event

IQPC CTS

August 24-26, 2020
Brussels, Belgium

Schedule a Meeting

Media

Articles

The New Normal in Clinical Trial Protection

Open chat

Hello! How can I help you?